Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver
暂无分享,去创建一个
B. Erdivanlı | Y. Tomak | D. Altuner | L. Tumkaya | A. Yılmaz | Y. Kalkan | L. Tümkaya | H. Bostan | Adnan Yilmaz | A. Yilmaz
[1] L. Goodnough,et al. In reply , 2014, Transfusion.
[2] P. Platt,et al. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model * , 2012, Anaesthesia.
[3] A. Funnell,et al. A further case of rocuronium-induced anaphylaxis treated with sugammadex. , 2011, British journal of anaesthesia.
[4] D. Ebo,et al. Rocuronium‐induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment , 2011, Anaesthesia.
[5] J. R. Ortiz-Gómez,et al. Allergy to low dose sugammadex , 2011, Anaesthesia.
[6] C. Miller,et al. Tryptase Staining of Mast Cells May Differentiate Eosinophilic Esophagitis from Gastroesophageal Reflux Disease , 2011, The American Journal of Gastroenterology.
[7] T. Turkstra,et al. Mitigation of rocuronium‐induced anaphylaxis by sugammadex: the great unknown , 2010, Anaesthesia.
[8] J. McKinlay,et al. Severe bronchospasm or anaphylaxis? , 2010, Anaesthesia.
[9] R. Guéant-Rodriguez,et al. Hypersensitivity reactions to neuromuscular blocking agents. , 2008, Current pharmaceutical design.
[10] G. Pejler,et al. Biology of mast cell tryptase , 2006 .
[11] J. Stensballe,et al. Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex: A Dose-finding and Safety Study , 2006, Anesthesiology.
[12] J. van Egmond,et al. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. , 2006, British journal of anaesthesia.
[13] G. Pejler,et al. Biology of mast cell tryptase. An inflammatory mediator. , 2006, The FEBS journal.
[14] Y. Okayama,et al. Development, migration, and survival of mast cells , 2006, Immunologic research.
[15] S. Ramael,et al. First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.
[16] P. Kam,et al. Mast cell tryptase: a review of its physiology and clinical significance , 2004, Anaesthesia.
[17] F. Alla,et al. Anaphylactic and Anaphylactoid Reactions Occurring during Anesthesia in France in 1999–2000 , 2003, Anesthesiology.
[18] M. Laxenaire,et al. Anaphylaxis during anaesthesia. Results of a two-year survey in France. , 2001, British journal of anaesthesia.
[19] M. Fisher,et al. Rocuronium: high risk for anaphylaxis? , 2001, British journal of anaesthesia.
[20] J. Proost,et al. Urinary, biliary and faecal excretion of rocuronium in humans. , 2000, British journal of anaesthesia.
[21] B. Finegan,et al. Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[22] T. Heier,et al. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: A report including 3 cases , 2000, Acta anaesthesiologica Scandinavica.
[23] B. Baldo,et al. Mast cell tryptase in anaesthetic anaphylactoid reactions. , 1998, British journal of anaesthesia.
[24] M. Rk. Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. , 1994 .
[25] R. Mirakhur. Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. , 1994, European journal of anaesthesiology. Supplement.
[26] L. Rasmussen,et al. Horner's syndrome after long-term epidural block. , 1992, European journal of anaesthesiology.